Skip to main content
. 2017 Jul 24;22(11):1400–1410. doi: 10.1634/theoncologist.2016-0498

Table 5. Overview of retrospective analyses on extremity STS.

image

a

Excluded low‐grade tumors.

b

Value for 5‐year OS.

c

Also included non‐extremity sites; 848 extremity STS were assessed.

Abbreviations: 5‐DSS, disease‐specific survival at 5 years; 5‐LRFS, local recurrence‐free survival rate at 5 years; 5‐MFS, metastasis‐free survival at 5 years; FU, follow‐up; OS, overall survival; NA, data not available; STS, soft tissue sarcomas.